New heart drug candidate HRS-1893 tested in healthy people for first time
Knowledge-focused
Completed
This early-phase trial tested a single oral dose of HRS-1893 in 20 healthy white male volunteers to see how the body processes the drug and whether it is safe. The study is a first step toward potentially treating hypertrophic cardiomyopathy, a condition where the heart muscle th…
Phase: EARLY_PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC